NEW YORK, Feb. 1 - Genaissance Pharmaceuticals and Biogen struck a deal to combine pharmacogenomic testing and drug development, the two companies said on Friday.
Registering provides access to this and other free content.
Already have an account?Login Now.
HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.
The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.
In Nature this week: glioma GWAS uncovers new risk loci, and more.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.